U.S. Machinery Stock News

Affirm Holdings has delivered a very strong 396.4% return over the past three years. However, current valuation checks and the Excess Returns intrinsic value estimate both indicate the stock is trading at a premium to what the fundamentals support. A roughly 396.4% gain over three years highlights how sharply expectations for Affirm Holdings have reset. This raises the bar for what the business needs to deliver next. Expectations for continued growth in Affirm Holdings' buy now, pay later...

In early August 2026, Remitly Global reported second-quarter sales of US$495.16 million and net income of US$205.91 million, alongside higher full-year 2026 revenue guidance and expectations of year-over-year net income growth. The company also unveiled the Remitly Global Card, a multi-currency account that lets cross-border customers spend, save, send, and access credit in one product, signaling an expansion beyond traditional remittances into broader digital financial services. Next, we’ll...

Tempus AI (TEM) is back in focus after CellCarta added the company to its CDx Commercialization Lab Network, linking Tempus Hub ordering to CellCarta testing and tightening access to oncology companion diagnostics for U.S. providers. See our latest analysis for Tempus AI. Tempus AI’s recent CellCarta partnership, PRISM2 publication and earnings update have arrived alongside a sharp 1-day share price return of 12.86% and a 7-day share price return of 18.65%. However, the year-to-date share...

Rithm Capital (RITM) reported second quarter 2026 results that gave investors fresh insight into the real estate focused asset manager. Sales reached US$182.13 million and net income was US$56.29 million. See our latest analysis for Rithm Capital. Following the second quarter update, Rithm Capital's share price sits at US$10.19, with a 30 day share price return of 11% and a year to date share price decline of 7.19%, while the 5 year total shareholder return of 69.07% highlights a stronger...

With global food prices sitting at multi year highs in July 2026, many investors are watching headline inflation and missing a quieter story. Lower used car prices and easing inflation in several countries are pointing to gentler price pressures. That can put more attention on companies where cash flows matter most. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that stand out today. The three stocks highlighted below are just a sample. The full...

In early August 2026, Paycom Software reported second-quarter results showing higher revenue and earnings than a year earlier, raised its full-year 2026 revenue outlook, declared a US$0.375 per-share dividend for September 2026, and disclosed that it had completed US$2.68 billion of share repurchases since 2016. Beyond the headline beat and guidance increase, management emphasized automation and AI-driven efficiencies as key drivers of margin expansion and stronger free cash flow, while...

On August 6, 2026, US Foods Holding Corp. reported higher second-quarter and year-to-date sales and net income, reaffirmed its 2026 net sales growth guidance of 4% to 6%, and completed share repurchases totaling 16,612,155 shares for about US$1.36 billion across two buyback authorizations. The combination of improved earnings, ongoing confidence in full-year performance, and sizable buybacks shrinking the share count highlights management’s focus on both operational execution and capital...

Astera Labs, Inc. reported past second-quarter 2026 results showing sales of US$392.4 million and net income of US$153.09 million, alongside six-month sales of US$700.76 million and net income of US$233.4 million, all substantially higher than a year earlier. Alongside these results, the company issued upbeat third-quarter 2026 guidance, projecting US$540 million to US$560 million in revenue and GAAP diluted EPS of US$0.87 to US$0.92, underscoring management’s confidence in its current AI...

EyePoint (EYPT) has just hit a key clinical milestone that puts fresh attention on its stock. The company completed enrollment ahead of schedule in its global Phase 3 COMO and CAPRI trials for DURAVYU in diabetic macular edema. See our latest analysis for EyePoint. The DURAVYU update comes after a sharp 8.26% 1 day share price return and 13.39% 7 day share price return, although the share price is still down 20.54% year to date while the 1 year total shareholder return is 35.78%. This...

Arcutis Biotherapeutics (ARQT) is back on investor radars after second quarter 2026 results showed revenue of $129.86 million, net income of $15.01 million, and raised full year net product sales guidance. See our latest analysis for Arcutis Biotherapeutics. The latest results and raised full year guidance have come alongside a 19.07% 3 month share price return and a 71.23% 1 year total shareholder return. However, shorter term share price returns over the past month and year to date have...

Seagate Technology Holdings recently reported fiscal fourth quarter 2026 sales of US$3,629 million and full-year sales of US$12.20 billion, alongside higher net income and earnings per share, affirmed a quarterly dividend of US$0.74 per share, issued fiscal first quarter 2027 revenue guidance of about US$4.10 billion, and earlier this month presented its technology roadmap at the Future of Memory and Storage 2026 conference in Santa Clara. Together, the stronger recent financial performance,...

Why Avery Dennison Stock Is Back in Focus After Q2 Avery Dennison (AVY) is drawing fresh attention after reporting higher Q2 2026 sales and net income, lifting its full-year earnings guidance, continuing its share buyback program, and declaring a new cash dividend. See our latest analysis for Avery Dennison. Avery Dennison’s recent Q2 earnings beat, higher full year guidance, share buybacks and the new dividend have coincided with a 10.25% 1 month share price return and a 6.08% 1 year total...

Super Micro Computer (SMCI) has drawn fresh attention after reporting more than US$60b in new AI focused orders in a single quarter, lifting its backlog to record levels while the stock trades near US$31. See our latest analysis for Super Micro Computer. Against this backdrop of record AI orders, Super Micro Computer’s recent share price moves tell a mixed story. The stock is up 5.96% on a 1 day basis and has a 30 day share price return of 9.96%. However, the 1 year total shareholder return...

Dow (DOW) is in focus after SweetNight selected the company and GoodBed to run independent mattress testing and consumer education, aiming to provide clearer performance data and build trust in mattress purchases. See our latest analysis for Dow. Dow's latest mattress testing partnership comes against a mixed share price backdrop, with the stock down 24.3% over the past 90 days, yet showing a 20.9% year to date share price return and a 45.5% 1 year total shareholder return. This points to...

In late July 2026, Crane Company reported second-quarter 2026 results showing sales rising to US$724.7 million and net income of US$95.9 million, alongside affirming a regular quarterly dividend of US$0.255 per share for payment on September 9, 2026. The company also raised its full-year 2026 sales growth guidance into the mid-20% range, highlighting acquisitions as a key driver of its expanded outlook. Now we’ll explore how Crane’s raised full-year sales guidance, driven by acquisitions,...

In early August 2026, Tripadvisor, Inc. reported past second-quarter 2026 results showing sales of US$441.9 million and net income of US$22.4 million, both lower than a year earlier, alongside weaker earnings per share and a first-half net loss. Management also outlined plans to sell TheFork for US$700 million and highlighted how AI-driven shifts in travel search and competition are prompting a reassessment of Tripadvisor’s core assets and business mix. We’ll now examine how the revenue...

In recent weeks, Medpace Holdings, Inc. experienced a “golden cross,” with its 50-day moving average crossing above the 200-day moving average, alongside upward revisions to earnings estimates. This combination of technical momentum and improving earnings expectations has drawn fresh attention to how the company’s fundamentals align with investors’ views on its future prospects. Next, we will examine how the golden cross and stronger earnings estimates interact with Medpace’s existing...

With the S&P 500 at record highs and valuations flashing similar signals to the late 1990s, many investors worry about where the next painful reset might land. Yet this is also when quality can matter most, as resilient dividend payers may stand out if lofty growth stories disappoint. This article walks through three stocks exposed to today’s AI driven enthusiasm and rich valuations, all drawn from a High-Quality Dividend Growth Stocks screener. The stocks covered below are just a starting...

Alpha and Omega Semiconductor (AOSL) heads into its upcoming fiscal Q4 2026 report with expectations for a shift from a small profit to a loss and lower year-over-year revenue. See our latest analysis for Alpha and Omega Semiconductor. Against that earnings backdrop, Alpha and Omega Semiconductor’s recent trading has been volatile, with a 1-day share price return of 8.25% and 7-day share price return of 13.67% contrasting with a 30-day share price return that declined 3.94%. Over longer...

WEX has rolled out SecureFuel for its North American fleet customers, using detailed transaction data, real-time vehicle information, and AI-powered models to block potentially unauthorized fuel purchases before approval, while also previewing its AI-based Actionable Insights tool for turning fleet and payment data into operational recommendations. This push into AI-driven fraud prevention and analytics deepens WEX’s integration of payments, telematics, and data intelligence, potentially...

Ashland Inc. previously declared a quarterly cash dividend of US$0.42 per share, payable on September 15, 2026, to shareholders of record on September 1, 2026, alongside reporting third-quarter fiscal 2026 sales of US$497 million and net income of US$16 million. The company also reached a cooperation agreement with Ancora Holdings Group, adding two independent directors and forming a Capital Allocation Advisory Committee, potentially reshaping how Ashland thinks about investment priorities...

Eli Lilly stock has climbed very sharply over the past five years, yet the current valuation checks send a more measured signal, with the Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market based multiples sit closer to fair value. That mix leaves investors weighing a strong price run against an intrinsic value estimate that suggests the shares may still trade below what the underlying cash flows imply. Eli Lilly has returned about 3.7x over the past 5 years, which...

Herbalife (HLF) is back in focus after its second quarter 2026 update, which combined higher sales, a swing to a quarterly net loss, raised full year sales guidance, and confirmation of an upcoming CFO transition. See our latest analysis for Herbalife. The earnings release and CFO succession plan have come alongside a more mixed share price path for Herbalife. The stock has a 1 day share price return of 7.3%, although the 30 day share price return is down 6.1%. Momentum has faded compared to...

The latest move from COMPASS Pathways (NasdaqGS:CMPS) is its new partnership with the U.S. Department of Veterans Affairs on the PIVOT trial, a multi site study of COMP360 in veterans. See our latest analysis for COMPASS Pathways. At a share price of US$13.54, COMPASS Pathways has a 7 day share price return of 19.3% and a 90 day share price return of 40.31%. The 1 year total shareholder return of 208.43% signals strong momentum despite a wider recent loss and a new shelf registration filing...